From the Journals

Chronic Cough's Double-Edged Sword

Study reveals chronic cough patients were twice as likely to receive opioid-containing cough suppressants, with 21% receiving prescriptions within a year of diagnosis.

Share

  • 1

    Patients with chronic cough were twice as likely to be prescribed opioid-containing cough suppressants.

  • 2

    21% of chronic cough patients received opioid-containing cough suppressant prescriptions within 1 year of diagnosis.

  • 3

    Medicaid recipients were significantly more likely to receive opioid-containing cough suppressant prescriptions.

  • 4

    The study found an increase in opioid-containing cough suppressants prescribing over the study period.

  • 5

    The research indicates a need for more effective non-opioid drugs to treat chronic cough and better implementation of diagnostic strategies to determine the cause of the cough.

Original Source(s)

Chronic Cough's Double-Edged Sword

Study reveals chronic cough patients were twice as likely to receive opioid-containing cough suppressants, with 21% receiving prescriptions within a year of diagnosis.

  • by Kerri Miller

  • August 22, 2024

  • 5 min

Related Content

2026 GOLD Report: A Landmark Revision Shaping the Future of COPD Management

  • by

  • December 21, 2025

  • 3 min
New Vaccine Prevents Severe RSV Illness

A recent study showed the new vaccine was more than 90% effective in the prevention of hospitalizations and emergency department visits due to RSV among those 60 years old or older.

Mepolizumab Reduces COPD Flares in Eosinophilic Patients

A new clinical trial found that adding mepolizumab to standard inhaled therapy significantly reduced moderate or severe COPD exacerbations in patients with high eosinophil counts, with a 21% lower annual rate and longer time to first flare.